Company description

PCRX is a pharmaceutical company specializing in developing and producing innovative treatments for pain management. Founded in 2007, the company has quickly made a name for itself as a leader in the industry, with its cutting-edge research and development efforts. PCRX's flagship product is an injectable painkiller called Exparel, which has been approved by the FDA for both hospital and outpatient use. This game-changing drug offers extended pain relief for up to 72 hours, significantly reducing the need for opioids and their associated side effects. In addition to Exparel, PCRX has a robust pipeline of other potential pain management solutions currently in various stages of clinical development. The company's commitment to improving pain management options and reducing opioid dependence has earned it recognition and numerous awards, making it a highly sought-after partner in the healthcare industry. PCRX's dedication to innovation and patient-centric approach has positioned it as a major player in the pharmaceutical market, with a promising future ahead.